Loading
Reproductive Tract Infections Research · Journal article
Venereology · August 11, 2026
A consensus or society position rather than new primary data.
This is a narrative perspective article synthesizing the epidemiology of STIs, antimicrobial resistance, and diagnostic approaches in sex workers in Africa, highlighting gaps between syndromic management practice and evidence-based molecular diagnostics. It does not report new empirical findings but rather frames priority public health strategies aligned with WHO 2022–2030 guidance.
Journal article. Sex workers in Africa, including female sex workers (FSWs), male sex workers (MSWs), and transgender/gender-diverse individuals..
Sex workers face heightened vulnerabilities to STIs due to occupational exposures, structural barriers, stigma, and criminalization. Non-HIV STIs including N. gonorrhoeae, C. trachomatis, T. pallidum, and viral hepatitis present significant co-morbidity alongside HIV. Drug resistance is documented across multiple pathogen classes: bacterial AMR in gonorrhoea and chlamydia, ARV resistance in HIV, and DAA resistance in hepatitis B and C.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
Clinicians and public health professionals should recognise that syndromic management of STIs in sex workers in African settings may be insufficient given documented antimicrobial and antiviral resistance; expansion of molecular diagnostic capacity and diagnostic stewardship aligned with WHO strategy is prioritised. This article frames policy and programme priorities rather than prescribing specific clinical changes based on trial evidence.
A perspective article synthesizing epidemiological evidence and expert recommendations on STI management, AMR, and diagnostic stewardship in sex workers across Africa, aligned with WHO strategy but not reporting original trial data.
Clinicians and public health professionals should recognise that syndromic management of STIs in sex workers in African settings may be insufficient given documented antimicrobial and antiviral resistance; expansion of molecular diagnostic capacity and diagnostic stewardship aligned with WHO strategy is prioritised. This article frames policy and programme priorities rather than prescribing specific clinical changes based on trial evidence.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no reported figures. That is a gap in the analysis, not a judgement about the study.
Infectious diseases remain a major global public health concern, disproportionately causing morbidity and mortality in low- and middle-income countries. Sexually Transmitted Infections (STIs) heavily affect sexually active populations. Sex workers, encompassing female sex workers (FSWs), male sex workers (MSWs), and transgender/gender-diverse individuals, face heightened vulnerabilities due to occupational exposures, structural barriers, stigma, and criminalization. While substantial focus has historically centered on HIV, non-HIV STIs such as Neisseria gonorrhoeae, Chlamydia trachomatis, Treponema pallidum, and viral hepatitis present significant co-morbidity. Crucially, drug resistance across these pathogens presents distinct biological and epidemiological challenges: bacterial antimicrobial resistance (AMR) in N. gonorrhoeae and C. trachomatis, antiretroviral (ARV) resistance in HIV, and direct-acting antiviral (DAA) resistance in hepatitis B and C. This perspective article synthesizes the current epidemiological landscape, critiques the reliance on syndromic management over molecular diagnostics (e.g., NAATs, point-of-care, and genomic surveillance), highlights diagnostic stewardship, and outlines priority public health strategies aligned with the WHO 2022–2030 Global Health Sector Strategies.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.